Why Join

For the first time in history, we can begin to see an end to Alzheimer's. But we need your help to get us there.

Scientists have made tremendous progress in the fight against the disease in just the past decade, and new studies launch every month. But researchers can't do the work alone: they need people like you to take part in their research.

Right now, 80% of studies are delayed because too few people sign up to participate. The Alzheimer's Prevention Registry, led by Banner Alzheimer's Institute, is changing this situation by connecting researchers with people willing to help advance their work.

Uniting scientists and people like you

First, we work with scientists to identify studies that need participants. Then, we look for Registry members who might be eligible and email them their new study opportunities.
Study participation is always optional, and you can choose to drop out at any time.
Your personal information will always remain confidential.
Joining the Registry is easy and free.
Besides study opportunities, members also receive the latest Alzheimer's news and research findings.

Creating a legacy: a world without Alzheimer's

The Registry is dedicated to creating a future without Alzheimer's. Registry Director and researcher Jessica Langbaum, Ph.D., watched her own grandfather struggle with the disease. In the video below, she explains how this motivates her work:

Watch Jessica' Story Here

New science, new hope

We've already helped several important studies get started. But with new ones launching all the time, that's just the beginning. Learn more about how the Registry works and why your help is so important.

A broad and diverse community dedicated to ending Alzheimer's

Scientists need people from all backgrounds to become involved in research. Prevention studies rely on healthy people without signs or symptoms of dementia to step up and join.

Not everyone will be eligible for every study: each one has its own inclusion criteria, and sometimes only a small percentage of people will meet them. This is why it's so important for us to build a large, broad and diverse community.

E-mail*

First Name *

Last Name *

Country *

Zip/Postal Code *

Already Registered?

Your privacy is extremely important! We promise to protect it - learn more

Recent News

A decline in dementia could be linked to healthier arteries

Recent articles have reported a possible decline in dementia. What is causing it? Researchers examined data from more than 1500 brain autopsies to find out. The results could help scientists better understand the link between Alzheimer’s disease and cardiovascular health.

Rare gene mutation delays onset of early Alzheimer’s by 30 years

A brother and sister in Medellin, Colombia benefitted from a rare gene mutation that protected them from developing the early onset Alzheimer’s disease that is rampant in their extended family. How did this gene stave off symptoms for so long? And how is it related to the case of a distant relative, discovered four years ago, whose cognitive decline was delayed 30 years by a different gene mutation?

MRI Image scan review shutterstock_cropped

Almost half of participants in anti-amyloid study show no disease progression in one year

Eli Lilly recently announced positive results for their Trailblazer-ALZ 2 Phase 3 clinical trial. The drug donanemab slowed cognitive and functional decline in a significant portion of study participants diagnosed with early-stage Alzheimer’s disease. This is the third drug reported to show a link between amyloid plaque clearance and lessening the progression of disease symptoms.